Alembic Pharmaceuticals informs about Press Release

27 Mar 2019 Evaluate

Alembic Pharmaceuticals has informed about press release regarding the Company received US Food & Drug Administration (USFDA) Approval for Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 20 mg.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

1036.30 -8.30 (-0.79%)
24-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1817.60
Dr. Reddys Lab 1351.25
Cipla 1475.90
Lupin 2168.30
Zydus Lifesciences 964.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.